A clinical update of using albumin as a drug vehicle - a commentary.
about
Albumin-based drug delivery: harnessing nature to cure diseaseUnraveling the Interaction between FcRn and Albumin: Opportunities for Design of Albumin-Based TherapeuticsAn in vitro and in vivo study of gemcitabine-loaded albumin nanoparticles in a pancreatic cancer cell line.An albumin-based tumor-targeted oxaliplatin prodrug with distinctly improved anticancer activity in vivo.177Lu-Labeled Phosphoramidate-Based PSMA Inhibitors: The Effect of an Albumin Binder on Biodistribution and Therapeutic Efficacy in Prostate Tumor-Bearing Mice.Role of protein-protein interactions in cytochrome P450-mediated drug metabolism and toxicityBSA-directed synthesis of CuS nanoparticles as a biocompatible photothermal agent for tumor ablation in vivo.Evaluation of Nonferrous Metals as Potential In Vivo Tracers of Transferrin-Based Therapeutics.Dual actions of albumin packaging and tumor targeting enhance the antitumor efficacy and reduce the cardiotoxicity of doxorubicin in vivo.Variant fatty acid-like molecules Conjugation, novel approaches for extending the stability of therapeutic peptides.Novel application of hydrophobin in medical science: a drug carrier for improving serum stabilityDeveloping an anticancer copper(II) pro-drug based on the nature of cancer cell and human serum albumin carrier IIA subdomain: mouse model of breast cancer.Albumin-based nanoparticles as methylprednisolone carriers for targeted delivery towards the neonatal Fc receptor in glomerular podocytesCould nanoparticle corona characterization help for biological consequence prediction?Protein engineering: a new frontier for biological therapeutics.Albumin and its application in drug delivery.Nanotechnology in the management of cervical cancer.Improvement of pyrazolo[3,4-d]pyrimidines pharmacokinetic properties: nanosystem approaches for drug delivery.PEG-b-PLA micelles and PLGA-b-PEG-b-PLGA sol-gels for drug delivery.Biotin/Folate-decorated Human Serum Albumin Nanoparticles of Docetaxel: Comparison of Chemically Conjugated Nanostructures and Physically Loaded Nanoparticles for Targeting of Breast Cancer.Protein based therapeutic delivery agents: Contemporary developments and challenges.Molecular mode of action of NKP-1339 - a clinically investigated ruthenium-based drug - involves ER- and ROS-related effects in colon carcinoma cell lines.Liposome-encapsulated plasmid DNA of telomerase-specific oncolytic adenovirus with stealth effect on the immune system.Biomineralization of Versatile CuS/Gd2 O3 Hybrid Nanoparticles for MR Imaging and Antitumor Photothermal Chemotherapy.Self-assembled albumin nanoparticles for combination therapy in prostate cancer.An Albumin-Oligonucleotide Assembly for Potential Combinatorial Drug Delivery and Half-Life Extension Applications.Legumain correlates with neuroblastoma differentiation and can be used in prodrug design.Spectroscopic investigation and in vitro cytotoxic activity toward HepG2 cells of a copper compound complexed with human serum albumin.Photochemical behavior of biosupramolecular assemblies of photosensitizers, cucurbit[n]urils and albumins.Making a case for albumin – a highly promising drug-delivery system.Cabazitaxel and indocyanine green co-delivery tumor-targeting nanoparticle for improved antitumor efficacy and minimized drug toxicity.Green and facile synthesis of a theranostic nanoprobe with intrinsic biosafety and targeting abilities.Novel Doxorubicin Derivatives: Synthesis and Cytotoxicity Study in 2D and 3D in Vitro Models.O2-generating MnO2 nanoparticles for enhanced photodynamic therapy of bladder cancer by ameliorating hypoxia.HSA-based multi-target combination therapy: regulating drugs' release from HSA and overcoming single drug resistance in a breast cancer model.Albumin-based drug delivery using cysteine 34 chemical conjugates - important considerations and requirements.Modulation of linoleic acid-binding properties of human serum albumin by divalent metal cations.Probing the Interactions of Cytotoxic [Pt(1S,2S-DACH)(5,6-dimethyl-1,10-phenanthroline)] and Its PtIV Derivatives with Human Serum.Multitriggered Tumor-Responsive Drug Delivery Vehicles Based on Protein and Polypeptide Coassembly for Enhanced Photodynamic Tumor Ablation.Molecular and Structural Traits of Insulin Receptor Substrate 1/LC3 Nuclear Structures and Their Role in Autophagy Control and Tumor Cell Survival.
P2860
Q26765789-1CB86D00-B330-498F-BDF6-086556D7752DQ27027238-85DB9245-4F92-471E-88E8-A3C39FDD1EB5Q27336445-3AABCC4C-DB9A-4947-8D8D-68E614584A7BQ33615268-9BD8AF38-709C-4462-81BE-7106EFC7392BQ33821017-5E791130-0061-47AF-AB73-AA5FB567158DQ34181972-8812034C-6B3E-4F61-B4A8-8F4D057BE577Q35672691-1B7224C2-A5C5-468E-868B-B98D9C91691DQ35782785-8ED75DD5-749D-49C5-92B7-C42F57F8D650Q36010344-B71D01EB-5E49-44D8-9684-32273B0B2112Q36363950-397F81F4-9E45-439B-9527-83D67353BA93Q36925453-9C6908E5-CC86-42BC-A1C2-B48242E2F6E5Q37687110-C74FD6E2-FF82-4834-8413-1B907244EFE6Q37714138-2C583F16-92CA-4BA5-9430-C263C6E575C4Q38259574-00E32BBB-9610-49E9-9990-E6D1B90009B0Q38286271-7781A6E3-727A-49EE-8668-5ED7709A05DFQ38292087-0801B516-9ADC-4223-B2C0-EC6CA6A7D4F1Q38370785-B26B41F7-844B-422E-93E3-E06F11CCD9BCQ38582337-39A8883A-9A91-4514-AF12-21978BD48E14Q38677767-63052942-B83D-4BAE-93E7-EAF585A1B1EEQ38848753-8D6E3C31-93E0-4BFD-B916-762F150DBCF2Q39273739-97DEF4CB-8BC1-42E7-8263-3CC469679513Q41134989-C4D7D357-1E27-42E5-A987-CF3525E06BB6Q42620815-9381CA1A-8923-4349-A10A-86FA3E6E1A87Q46277339-34A61090-7CF8-45DC-8BAD-C449D9FC981BQ47101813-E5024122-2ABC-4722-B2C6-C0C0DF56FCDAQ47288556-5863497F-FB0F-4024-8603-6E65BCB33B2DQ47744587-3F6C50EE-5391-4091-B201-B814567BF61AQ47904094-39FD1DDF-675B-444A-B240-4A56349D798FQ48088568-F6F2BED0-D381-403D-97F4-E6DCC2A6FE32Q48496247-16701D1B-818E-434F-AB80-13233A55E956Q49058815-98F69702-0C4D-4E85-958D-6AEEA7AF4065Q49115686-E65334C6-B9EA-4E37-A43B-BCCED2DC4B08Q49240708-4119208D-CC07-4844-9107-0DF1416B2CBEQ49788150-97D42B1E-9E5B-405A-9BA9-3E3DF7881B76Q49928163-F6F7E39E-2C1B-461C-A11A-A285FE96613FQ50616154-0143D54F-751F-4047-9944-C74A767061AAQ50955973-4D586D15-18EB-4B12-9B6D-5F636297FAE0Q51135499-3C110C69-F590-4DB3-AAA3-145B325D9463Q51165569-314C6648-FFDC-4597-BF43-CB7560BD9A41Q52684404-A9805D90-E8E1-4E01-BB95-F4789FC5E585
P2860
A clinical update of using albumin as a drug vehicle - a commentary.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
A clinical update of using albumin as a drug vehicle - a commentary.
@en
type
label
A clinical update of using albumin as a drug vehicle - a commentary.
@en
prefLabel
A clinical update of using albumin as a drug vehicle - a commentary.
@en
P1476
A clinical update of using albumin as a drug vehicle - a commentary.
@en
P2093
Felix Kratz
P304
P356
10.1016/J.JCONREL.2014.03.013
P407
P577
2014-03-15T00:00:00Z